Years ago I invested in a company called Exelixis.biotech focused on cancer. The stock plummeted to around 1.40 a share but they had a drug in clinical trials, phase 3 . When it was approved the drug was a winner ..Today the company is in a great growth trajectory and around 22 or 23 bucks a share. With biotech you have to look at them differently than other companies and be patient if you believe in the product.. being on the OTC adds a layer of complexity but ultimately it’s the product . Leronlimab I s passing all the tests as it goes through trials rather quickly..these trials normally take years. These are happening , especially for Covid, in months..